UPDATE : Friday, October 19, 2018
Bayer’s blood thinner wins broader indication for coronary artery disease by Nam Doo-hyun 2018-10-19 16:34
Listed pharmaceuticals’ operating margins decline to 12.2 pct. in H1 by Lee Hye-seon 2018-10-19 14:20
Seegene to speed up advances into China by Lee Han-soo 2018-10-19 11:46
Novo Nordisk Korea releases research results for rapid-acting insulin by Lee Han-soo 2018-10-18 17:22
Trivalent flu shots out of stock, quadrivalent products selling poorly by So Jae-hyeon 2018-10-18 13:59
Developing natural product-derived drugs gets trickier under Nagoya Protocol by So Jae-hyeon 2018-10-18 12:00
Theragen Etex promotes gene sequencing feat in US conference by Lee Han-soo 2018-10-17 16:45
CrystalGenomics hopes to test new leukemia drug early next year by Nam Doo-hyun 2018-10-16 16:17
Drug regulator raids 4 cell therapy makers by So Jae-hyeon 2018-10-16 15:28
Chong Kun Dang recruits European researchers for autoimmune disease drug by Lee Han-soo 2018-10-16 12:08
‘AI-based drug development to broaden gap between pharmaceuticals’ by So Jae-hyeon 2018-10-15 15:37
[News Focus] Handok sidesteps regulation to promote anti-Alzheimer drink by So Jae-hyeon 2018-10-15 14:52
Sanofi-Aventis Korea unveils sub-analysis for dyslipidemia therapy by Lee Han-soo 2018-10-12 17:25
Abbvie’s hepatitis C drug expands indication by Lee Han-soo 2018-10-12 15:40
[News Focus] Celltrion to accelerate US entry on imminent FDA approval by So Jae-hyeon 2018-10-12 15:40
Bridge Bio completes phase-1 study for ulcerative colitis drug in US by Lee Han-soo 2018-10-12 13:38
Boryung to export anticancer drugs to Philippine by Lee Han-soo 2018-10-12 13:26
[News Focus] Authorities close in on drug firm owners in bribery case by So Jae-hyeon 2018-10-11 16:33
YD Life Science wins source tech for anti-cancer gene therapy by Lee Han-soo 2018-10-11 14:46
BMS to test cabiralizumab+nivolumab for pancreatic cancer by Lee Hye-seon 2018-10-11 14:23
Back to Top